Bone Biologics Corp WarrantsBBLGW
About: Bone Biologics Corp is a healthcare solutions provider based in the United States. As a biotechnology firm, it engages its efforts in developing therapeutics to aid bone regeneration. The company's portfolio comprises its lead product, NELL-1, which is a bone void filler. Bone Biologics' technology has applications in the surgical specialties of spinal, orthopedic, general orthopedic, plastic reconstruction, neurosurgery, interventional radiology, and sports medicine.
Employees: 2
Fund manager confidence
Based on 2025 Q1 regulatory disclosures by fund managers ($100M+ AUM)
50% more funds holding
Funds holding: 2 [Q4 2024] → 3 (+1) [Q1 2025]
0.44% less ownership
Funds ownership: 1.66% [Q4 2024] → 1.22% (-0.44%) [Q1 2025]
62% less capital invested
Capital invested by funds: $1.48M [Q4 2024] → $557K (-$921K) [Q1 2025]
Research analyst outlook
We haven’t received any recent analyst ratings for BBLGW.
Financial journalist opinion
We haven’t received any recent news articles for BBLGW.